MINERVA NEUROSCIENCES INC (NERV) Forecast, Price Target & Analyst Ratings
NASDAQ:NERV • US6033802058
6.01 USD
+0.07 (+1.18%)
Last: Mar 6, 2026, 08:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MINERVA NEUROSCIENCES INC (NERV).
Forecast Snapshot
Consensus Price Target
$4.59
-23.63% Downside
Next Earnings Forecast
Release DateMar 10, 2026
PeriodQ4 / 2025
EPS Estimate-$0.31
Revenue Estimate
ChartMill Buy Consensus
45.71%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$4.59
Upside
-23.63%
From current price of $6.01 to mean target of $4.59, Based on 7 analyst forecasts
Low
$4.04
Median
$4.59
High
$5.25
Price Target Revisions
1 Month
0.00%
3 Months
12.50%
Price Target Summary
7 analysts have analysed NERV and the average price target is 4.59 USD. This implies a price decrease of -23.63% is expected in the next year compared to the current price of 6.01.
The average price target has been revised upward by 12.5% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
45.71%
NERV was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about NERV.
In the previous month the buy percentage consensus was at a similar level.
NERV was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-11-06 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-02-26 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-06 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-08-07 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-05-02 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-02-27 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-08-02 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2023-05-16 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-05-02 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-03-09 | HC Wainwright & Co. | Reiterate | Neutral |
| 2022-11-10 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-10-17 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2022-03-04 | HC Wainwright & Co. | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 10, 2026
PeriodQ4 / 2025
EPS Estimate-$0.31
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q45.36%
Number of Analysts4
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-172.73%
Next Earnings Summary
NERV is expected to report earnings on 3/10/2026. The consensus EPS estimate for the next earnings is -0.31 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 41.18M | 339.997K -100.00% | 39.012M | 81.965M 110.10% | 223.77M 173.01% | 279.48M 24.90% | |||||||||
| EBITDA YoY % growth | -51.71M -25.63% | -75.85M -46.68% | 1.87M 102.47% | N/A -2,526.20% | N/A 44.41% | N/A 8.45% | N/A 4.81% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -51.73M -25.65% | -75.87M -46.67% | 1.85M 102.44% | -32.323M -2,552.43% | -26.164M 44.39% | -21.42M 8.36% | -24.151M 4.84% | -14.824M 32.62% | -38.559M -160.11% | -45.657M -18.41% | -7.846M 82.82% | 4.329M 155.18% | 99.515M 2,198.80% | 78.54M -21.08% | |
| Operating Margin | N/A | N/A | 4.49% | -9,506.80% | N/A | N/A | N/A | N/A | N/A | N/A | -20.11% | 5.28% | 44.47% | 28.10% | |
| EPS YoY % growth | -10.32 -18.35% | -14.88 -44.19% | 0.40 102.69% | -6.96 -2,400.00% | -4.56 34.57% | -4.35 19.44% | -0.31 31.55% | -1.62 51.15% | -0.81 50.00% | -0.62 23.90% | -0.26 58.68% | 0.62 344.00% | 1.81 190.16% | 14.74 716.38% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.31 45.36% | -0.14 71.44% | -0.20 53.74% | -0.24 34.72% | -0.23 25.00% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.57M 21.06% | -6.528M -67.26% | -11.118M -229.50% | -14.178M -398.45% | -16.218M -354.29% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
21.96%
EPS Next 5 Year
16.95%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
MINERVA NEUROSCIENCES INC / NERV Forecast FAQ
Can you provide the average price target for MINERVA NEUROSCIENCES INC stock?
7 analysts have analysed NERV and the average price target is 4.59 USD. This implies a price decrease of -23.63% is expected in the next year compared to the current price of 6.01.
When does MINERVA NEUROSCIENCES INC (NERV) report earnings?
MINERVA NEUROSCIENCES INC (NERV) will report earnings on 2026-03-10, after the market close.
What are the consensus estimates for MINERVA NEUROSCIENCES INC (NERV) next earnings?
The consensus EPS estimate for the next earnings of MINERVA NEUROSCIENCES INC (NERV) is -0.31 USD and the consensus revenue estimate is 0 USD.
How many analysts cover MINERVA NEUROSCIENCES INC (NERV) stock?
The number of analysts covering MINERVA NEUROSCIENCES INC (NERV) is 7.